262 related articles for article (PubMed ID: 368262)
1. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
Dinarello CA; Elin RJ; Chedid L; Wolff SM
J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
[TBL] [Abstract][Full Text] [Related]
2. Central pyrogenic activity of muramyl dipeptide.
Riveau G; Masek K; Parant M; Chedid L
J Exp Med; 1980 Oct; 152(4):869-77. PubMed ID: 7420023
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.
Parant M; Riveau G; Parant F; Chedid L
Am J Physiol; 1984 Sep; 247(3 Pt 1):C169-74. PubMed ID: 6476105
[TBL] [Abstract][Full Text] [Related]
4. Decrease in pyrogenicity of muramyl dipeptide after coupling with luteinizing hormone-releasing hormone.
Riveau G; Hosmalin A; Carelli C; Lefrancier P; Chedid L
J Leukoc Biol; 1988 Nov; 44(5):448-54. PubMed ID: 3053952
[TBL] [Abstract][Full Text] [Related]
5. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
6. Changes in rabbit febrile responses to muramyl dipeptide (MDP) after coupling to a synthetic carrier.
Riveau G; Parant M; Chedid L
J Leukoc Biol; 1984 Aug; 36(2):111-22. PubMed ID: 6589335
[TBL] [Abstract][Full Text] [Related]
7. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
8. Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative.
Damais C; Riveau G; Parant M; Gerota J; Chedid L
Int J Immunopharmacol; 1982; 4(5):451-62. PubMed ID: 6982246
[TBL] [Abstract][Full Text] [Related]
9. Human monocytoid cell lines as indicators of endotoxin: comparison with rabbit pyrogen and Limulus amoebocyte lysate assay.
Eperon S; De Groote D; Werner-Felmayer G; Jungi TW
J Immunol Methods; 1997 Sep; 207(2):135-45. PubMed ID: 9368640
[TBL] [Abstract][Full Text] [Related]
10. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
Parant M; Riveau G; Chedid L
Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
[TBL] [Abstract][Full Text] [Related]
12. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, mass spectral characterization and immunoadjuvant activity of some novel lipophilic derivatives of muramyl dipeptides.
Jain RK; Gupta CM; Saxena RK; Saxena RP; Saxena KC; Shukla R; Anand N; Costello CE
Chem Phys Lipids; 1986; 41(3-4):237-64. PubMed ID: 3815623
[TBL] [Abstract][Full Text] [Related]
14. Role of the hepatic function in the development of the pyrogenic tolerance to muramyl dipeptide.
Ferreira ME; Coelho MM; Pelá IR
Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R162-9. PubMed ID: 11404290
[TBL] [Abstract][Full Text] [Related]
15. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
[TBL] [Abstract][Full Text] [Related]
16. Specific absorption with monoclonal antibodies to muramyl dipeptide of the pyrogenic and somnogenic activities of rabbit monokine.
Chedid L; Bahr GM; Riveau G; Krueger JM
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5888-91. PubMed ID: 6207533
[TBL] [Abstract][Full Text] [Related]
17. Course of fever response to repeated administration of sublethal doses of lipopolysaccharides, polyinosinic:polycytidylic acid and muramyl dipeptide to rabbits.
Soszynski D; Kozak W; Szewczenko M
Experientia; 1991 Jan; 47(1):43-7. PubMed ID: 1999244
[TBL] [Abstract][Full Text] [Related]
18. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
Dewhirst FE
Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
[TBL] [Abstract][Full Text] [Related]
19. Somnogenic activity of muramyl peptide-derived immune adjuvants.
Johannsen L; Obál F; Kapás L; Kovalzon V; Krueger JM
Int J Immunopharmacol; 1994 Feb; 16(2):109-16. PubMed ID: 8181899
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
Chedid L; Parant M; Parant F; Audibert F; Lefrancier F; Choay J; Sela M
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6557-61. PubMed ID: 293743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
